All lobbying filings

DB3, LLC (FKA THE DASCHLE GROUP)

DB3, LLC (FKA THE DASCHLE GROUP) filed a Q1 report for OTSUKA AMERICA PHARMACEUTICAL, INC on April 20, 2026, reporting $30,000 in lobbying income.

Lobbying for OTSUKA AMERICA PHARMACEUTICAL, INC · Pharmaceutical manufacturer

All filings by DB3, LLC (FKA THE DASCHLE GROUP) · Everything OTSUKA AMERICA PHARMACEUTICAL, INC has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Income

$30,000

What the client paid this registrant for the period.

Client based in

New Jersey

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Research, development, and reimbursement of novel serotonergic agonists for mental health conditions

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.